Literature DB >> 2322916

Cholestatic jaundice associated with lovastatin (Mevacor) therapy.

M J McQueen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322916      PMCID: PMC1451935     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  A general assessment of the safety of HMG CoA reductase inhibitors (statins).

Authors:  Donald M Black
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

Review 2.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Lovastatin and cholestasis.

Authors:  E M Yoshida; A Levin
Journal:  CMAJ       Date:  1993-02-01       Impact factor: 8.262

5.  Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin.

Authors:  S Grimbert; D Pessayre; C Degott; J P Benhamou
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

6.  Cholestatic jaundice associated with lovastatin (mevacor) therapy.

Authors:  J A Geddes
Journal:  CMAJ       Date:  1990-07-01       Impact factor: 8.262

7.  Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Rosanna Villani; Eliano Pio Navarese; Francesco Cavallone; Jacek Kubica; Francesco Bellanti; Antonio Facciorusso; Gianluigi Vendemiale; Gaetano Serviddio
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-05

8.  Rosuvastatin-Induced Dizziness and Pruritus: A Case Report and Summary of Statin-Associated Dizziness and Pruritus.

Authors:  Sara Malik; Philip R Cohen
Journal:  Cureus       Date:  2022-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.